EP4-ANTAGONIST

European patent · EP3632898 · Deleted

Register entry

Publication number
EP3632898
Application number
EP18805980
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 21, 2018
Published
Apr 8, 2020
Granted
Jul 12, 2023
Deleted
Dec 24, 2024
Reason
Annual fee unpaid
IPC classes
C07D 209/08 (2006.01)
A61K 31/427 (2006.01)
A61P 37/00 (2006.01)
A61P 43/00 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
Priority
JP 2017100512 22.05.2017
PCT application
PCT/JP2018/019440 21.05.2018
PCT publication
WO2018/216640 29.11.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 24, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.12.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.12.2024

  2. May 22, 2024

    Change

    Published in Swissreg on 22.05.2024

  3. Jul 12, 2023

    Granted

    Published in Swissreg on 12.07.2023

Parties

Holder

Ono Pharmaceutical Co., Ltd.

ONO Pharmaceutical Co., Ltd.

1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, JP

Inventor

TANI, Kousuke

Mishima-gun Osaka 618-8585, JP

HIGUCHI, Satonori

Mishima-gun Osaka 618-8585, JP

ASADA, Masaki

Mishima-gun Osaka 618-8585, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.